Rosiglitazone pretreatment protects against lipopolysaccharide-induced fetal demise through inhibiting placental inflammation

This publication has 66 references indexed in Scilit:

• Vitamin D3 inhibits lipopolysaccharide-induced placental inflammation through reinforcing interaction between vitamin D receptor and nuclear factor kappa B p65 subunit
  Scientific Reports, 2015
• CXCR3 blockade protects against Listeria monocytogenes infection–induced fetal wastage
  Journal of Clinical Investigation, 2015
• Supplementation With Vitamin D3 During Pregnancy Protects Against Lipopolysaccharide-Induced Neural Tube Defects Through Improving Placental Folate Transportation
  Toxicological Sciences, 2015
• Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia
  Journal of Experimental Medicine, 2014
• PPAR activation as a regulator of lipid metabolism, nitric oxide production and lipid peroxidation in the placenta from type 2 diabetic patients
  Molecular and Cellular Endocrinology, 2013
• PPARγ signaling and metabolism: the good, the bad and the future
  Nature Medicine, 2013
• Zinc Supplementation during Pregnancy Protects against Lipopolysaccharide-Induced Fetal Growth Restriction and Demise through Its Anti-inflammatory Effect
  The Journal of Immunology, 2012
• Melatonin protects against lipopolysaccharide‐induced intra‐uterine fetal death and growth retardation in mice
  Journal of Pineal Research, 2005
• Altered Placental Oxidative Stress Status in Gestational Diabetes Mellitus
  Placenta, 2004
• Protective effect of N-acetylcysteine against fetal death and preterm labor induced by maternal inflammation
  American Journal of Obstetrics and Gynecology, 2003